The Europe Nanotechnology Drug Delivery Market would witness market growth of 8.5% CAGR during the forecast period (2023-2030).
In the realm of neurological drug delivery, nanotechnology has shown promise in treating conditions such as Alzheimer's disease, Parkinson's disease, and brain tumors. Nanocarriers, including polymeric nanoparticles and lipid-based nanocarriers, have been investigated for their potential to enhance drug delivery to the brain and improve therapeutic outcomes. Furthermore, the development of nanotheranostics-nanoparticles that combine therapeutic and diagnostic functions—holds the potential for real-time monitoring and personalized treatment strategies in neurological disorders.
Additionally, nanotechnology is crucial in addressing challenges associated with infectious diseases, offering innovative solutions for drug delivery and diagnostics. Nanoparticles can enhance the delivery of antimicrobial agents, antiviral drugs, and vaccines. In the context of antibiotic resistance, nanocarriers can improve the efficacy of existing antibiotics and potentially overcome resistance mechanisms. The development of nano vaccines represents a notable advancement in infectious disease applications of nanotechnology. Nanoparticles can serve as effective carriers for antigens, promoting targeted immune responses and enhancing vaccine efficacy. This approach holds promise for addressing global health challenges, including the ongoing quest for effective vaccination strategies against emerging infectious diseases.
Cancer is a major health concern globally, including within the European Union. The UK has established itself as a hub for research and innovation, particularly in the medical and pharmaceutical sectors. With a growing emphasis on medical technology, research institutions, and companies are likely to invest in nanotechnology for drug delivery systems. This could lead to the development of advanced and efficient drug delivery methods. As per the data provided in 2023 by the International Trade Administration, the UK medical technology sector generates an annual turnover of approximately $33 billion, it has a strong foundation of mostly small to medium-sized companies around the country. Thus, rising cancer cases and the medical technology sector in Europe will boost the demand for these drug delivery in the coming years.
The Germany market dominated the Europe Nanotechnology Drug Delivery Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $9,419.9 Million by 2030. The UK market is exhibiting a CAGR of 7.5% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.3% during (2023 - 2030).
Free Valuable Insights: The Global Nanotechnology Drug Delivery Market will Hit USD 153 Billion by 2030, at a CAGR of 8.7%
Based on Formulation, the market is segmented into Polymer-Based Nanomedicine, Lipid-Based Nanomedicine, Nanocrystals, and Others. Based on Application, the market is segmented into Oncology & Hematology, Infectious Diseases, Orthopedics, Neurology, Immunology, Urology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- AbbVie, Inc.
- Pfizer Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Novartis AG
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Amgen, Inc.
- Merck KGaA
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
Europe Nanotechnology Drug Delivery Market Report Segmentation
By Formulation
- Polymer-Based Nanomedicine
- Lipid-Based Nanomedicine
- Nanocrystals
- Others
By Application
- Oncology & Hematology
- Infectious Diseases
- Orthopedics
- Neurology
- Immunology
- Urology
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Nanotechnology Drug Delivery Market, by Formulation
1.4.2 Europe Nanotechnology Drug Delivery Market, by Application
1.4.3 Europe Nanotechnology Drug Delivery Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Nanotechnology Drug Delivery Market, by Formulation
4.1 Europe Polymer-Based Nanomedicine Market, by Country
4.2 Europe Lipid-Based Nanomedicine Market, by Country
4.3 Europe Nanocrystals Market, by Country
4.4 Europe Others Market, by Country
Chapter 5. Europe Nanotechnology Drug Delivery Market, by Application
5.1 Europe Oncology & Hematology Market, by Country
5.2 Europe Infectious Diseases Market, by Country
5.3 Europe Orthopedics Market, by Country
5.4 Europe Neurology Market, by Country
5.5 Europe Immunology Market, by Country
5.6 Europe Urology Market, by Country
5.7 Europe Others Market, by Country
Chapter 6. Europe Nanotechnology Drug Delivery Market, by Country
6.1 Germany Nanotechnology Drug Delivery Market
6.1.1 Germany Nanotechnology Drug Delivery Market, by Formulation
6.1.2 Germany Nanotechnology Drug Delivery Market, by Application
6.2 UK Nanotechnology Drug Delivery Market
6.2.1 UK Nanotechnology Drug Delivery Market, by Formulation
6.2.2 UK Nanotechnology Drug Delivery Market, by Application
6.3 France Nanotechnology Drug Delivery Market
6.3.1 France Nanotechnology Drug Delivery Market, by Formulation
6.3.2 France Nanotechnology Drug Delivery Market, by Application
6.4 Russia Nanotechnology Drug Delivery Market
6.4.1 Russia Nanotechnology Drug Delivery Market, by Formulation
6.4.2 Russia Nanotechnology Drug Delivery Market, by Application
6.5 Spain Nanotechnology Drug Delivery Market
6.5.1 Spain Nanotechnology Drug Delivery Market, by Formulation
6.5.2 Spain Nanotechnology Drug Delivery Market, by Application
6.6 Italy Nanotechnology Drug Delivery Market
6.6.1 Italy Nanotechnology Drug Delivery Market, by Formulation
6.6.2 Italy Nanotechnology Drug Delivery Market, by Application
6.7 Rest of Europe Nanotechnology Drug Delivery Market
6.7.1 Rest of Europe Nanotechnology Drug Delivery Market, by Formulation
6.7.2 Rest of Europe Nanotechnology Drug Delivery Market, by Application
Chapter 7. Company Profiles
7.1 AbbVie, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.6 SWOT Analysis
7.3 Johnson & Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 SWOT Analysis
7.4 Novartis AG
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bristol-Myers Squibb Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 AstraZeneca PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Amgen, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Merck KGaA
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 SWOT Analysis
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
TABLE 1 Europe Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 2 Europe Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 3 Europe Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 4 Europe Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 5 Europe Polymer-Based Nanomedicine Market, by Country, 2019 - 2022, USD Million
TABLE 6 Europe Polymer-Based Nanomedicine Market, by Country, 2023 - 2030, USD Million
TABLE 7 Europe Lipid-Based Nanomedicine Market, by Country, 2019 - 2022, USD Million
TABLE 8 Europe Lipid-Based Nanomedicine Market, by Country, 2023 - 2030, USD Million
TABLE 9 Europe Nanocrystals Market, by Country, 2019 - 2022, USD Million
TABLE 10 Europe Nanocrystals Market, by Country, 2023 - 2030, USD Million
TABLE 11 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 12 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 13 Europe Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 14 Europe Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 15 Europe Oncology & Hematology Market, by Country, 2019 - 2022, USD Million
TABLE 16 Europe Oncology & Hematology Market, by Country, 2023 - 2030, USD Million
TABLE 17 Europe Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 18 Europe Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 19 Europe Orthopedics Market, by Country, 2019 - 2022, USD Million
TABLE 20 Europe Orthopedics Market, by Country, 2023 - 2030, USD Million
TABLE 21 Europe Neurology Market, by Country, 2019 - 2022, USD Million
TABLE 22 Europe Neurology Market, by Country, 2023 - 2030, USD Million
TABLE 23 Europe Immunology Market, by Country, 2019 - 2022, USD Million
TABLE 24 Europe Immunology Market, by Country, 2023 - 2030, USD Million
TABLE 25 Europe Urology Market, by Country, 2019 - 2022, USD Million
TABLE 26 Europe Urology Market, by Country, 2023 - 2030, USD Million
TABLE 27 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 28 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 29 Europe Nanotechnology Drug Delivery Market, by Country, 2019 - 2022, USD Million
TABLE 30 Europe Nanotechnology Drug Delivery Market, by Country, 2023 - 2030, USD Million
TABLE 31 Germany Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 32 Germany Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 33 Germany Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 34 Germany Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 35 Germany Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 36 Germany Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 37 UK Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 38 UK Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 39 UK Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 40 UK Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 41 UK Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 42 UK Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 43 France Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 44 France Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 45 France Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 46 France Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 47 France Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 48 France Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 49 Russia Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 50 Russia Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 51 Russia Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 52 Russia Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 53 Russia Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 54 Russia Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 55 Spain Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 56 Spain Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 57 Spain Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 58 Spain Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 59 Spain Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 60 Spain Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 61 Italy Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 62 Italy Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 63 Italy Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 64 Italy Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 65 Italy Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 66 Italy Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 67 Rest of Europe Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 68 Rest of Europe Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 69 Rest of Europe Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 70 Rest of Europe Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 71 Rest of Europe Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 72 Rest of Europe Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 73 Key information – AbbVie, Inc.
TABLE 74 Key Information – Pfizer, Inc.
TABLE 75 Key Information – Johnson & Johnson
TABLE 76 Key Information – Novartis AG
TABLE 77 Key Information – Bristol-Myers Squibb Company
TABLE 78 KEY INFORMATION – AstraZeneca PLC
TABLE 79 Key Information – Amgen, Inc.
TABLE 80 key Information – Merck KGaA
TABLE 81 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 82 Key Information – Sanofi S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Nanotechnology Drug Delivery Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Nanotechnology Drug Delivery Market
FIG 4 Porter’s Five Forces Analysis - Nanotechnology Drug Delivery Market
FIG 5 Europe Nanotechnology Drug Delivery Market share, by Formulation, 2022
FIG 6 Europe Nanotechnology Drug Delivery Market share, by Formulation, 2030
FIG 7 Europe Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2030, USD Million
FIG 8 Europe Nanotechnology Drug Delivery Market share, by Application, 2022
FIG 9 Europe Nanotechnology Drug Delivery Market share, by Application, 2030
FIG 10 Europe Nanotechnology Drug Delivery Market, by Application, 2019 - 2030, USD Million
FIG 11 Europe Nanotechnology Drug Delivery Market share, by Country, 2022
FIG 12 Europe Nanotechnology Drug Delivery Market share, by Country, 2030
FIG 13 Europe Nanotechnology Drug Delivery Market, by Country, 2019 - 2030, USD Million
FIG 14 Swot Analysis: AbbVie, Inc.
FIG 15 SWOT Analysis: Pfizer, Inc.
FIG 16 SWOT Analysis: Johnson & Johnson
FIG 17 SWOT Analysis: Novartis AG
FIG 18 SWOT Analysis: Bristol-Myers Squibb Company
FIG 19 SWOT Analysis: AstraZeneca PLC
FIG 20 Swot Analysis: Amgen, Inc.
FIG 21 Swot Analysis: Merck KGaA
FIG 22 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 23 Swot Analysis: Sanofi S.A.